| 摘要 |
The invention relates to the use of at least one physiologically compatible compound of general formula (I), wherein U represents -CH2-CH(OH)-CH2- or -CHR-CO-NH-(CH2)n-CO, with R meaning a hydrogen atom or a methyl group and n meaning the numbers 1 to 10, and T represents a tumour-specific radical of biological or synthetic origin, for producing preparations for neutron capture and photon activation therapy. |
